The gut microbiome is a vast and complex ecosystem that plays a critical role in a wide range of health conditions, including obesity, diabetes, inflammatory bowel disease, and even mental health disorders.
In collaboration with Bayer AG, this detailed landscape analysis reveals emerging trends in microbiome therapies, the wide range of diseases that could be impacted, and a deeper dive into the clinical pipeline, emerging players, and key influencers. Explore more below.
